RAP1A and early-onset autosomal dominant Alzheimer disease: The inhibition of Rap1 interaction with PDE6δ restrains disease-associated abnormal Ca2+ influx and neuronal hyperactivity and confers neuroprotection in models of Alzheimer’s disease [24].